229 related articles for article (PubMed ID: 24035896)
1. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Björkhem I; Lövgren-Sandblom A; Leoni V; Meaney S; Brodin L; Salveson L; Winge K; Pålhagen S; Svenningsson P
Neurosci Lett; 2013 Oct; 555():102-5. PubMed ID: 24035896
[TBL] [Abstract][Full Text] [Related]
2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
3. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
[TBL] [Abstract][Full Text] [Related]
4. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
5. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis.
Leoni V; Masterman T; Diczfalusy U; De Luca G; Hillert J; Björkhem I
Neurosci Lett; 2002 Oct; 331(3):163-6. PubMed ID: 12383922
[TBL] [Abstract][Full Text] [Related]
6. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic use of cerebral and extracerebral oxysterols.
Leoni V; Masterman T; Mousavi FS; Wretlind B; Wahlund LO; Diczfalusy U; Hillert J; Björkhem I
Clin Chem Lab Med; 2004 Feb; 42(2):186-91. PubMed ID: 15061359
[TBL] [Abstract][Full Text] [Related]
8. On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review).
Björkhem I; Leoni V; Svenningsson P
J Steroid Biochem Mol Biol; 2019 Apr; 188():86-89. PubMed ID: 30586624
[TBL] [Abstract][Full Text] [Related]
9. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
10. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
[TBL] [Abstract][Full Text] [Related]
11. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.
Leoni V; Masterman T; Patel P; Meaney S; Diczfalusy U; Björkhem I
J Lipid Res; 2003 Apr; 44(4):793-9. PubMed ID: 12562838
[TBL] [Abstract][Full Text] [Related]
12. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.
Lütjohann D; Breuer O; Ahlborg G; Nennesmo I; Sidén A; Diczfalusy U; Björkhem I
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9799-804. PubMed ID: 8790411
[TBL] [Abstract][Full Text] [Related]
14. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.
Björkhem I; Starck L; Andersson U; Lütjohann D; von Bahr S; Pikuleva I; Babiker A; Diczfalusy U
J Lipid Res; 2001 Mar; 42(3):366-71. PubMed ID: 11254748
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
[TBL] [Abstract][Full Text] [Related]
16. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.
Kölsch H; Heun R; Kerksiek A; Bergmann KV; Maier W; Lütjohann D
Neurosci Lett; 2004 Sep; 368(3):303-8. PubMed ID: 15364416
[TBL] [Abstract][Full Text] [Related]
17. Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice.
Meaney S; Lütjohann D; Diczfalusy U; Björkhem I
Biochim Biophys Acta; 2000 Jul; 1486(2-3):293-8. PubMed ID: 10903480
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol.
Lütjohann D; Björkhem I; Locatelli S; Dame C; Schmolling J; von Bergmann K; Fahnenstich H
Acta Paediatr; 2001 Jun; 90(6):652-7. PubMed ID: 11440099
[TBL] [Abstract][Full Text] [Related]
19. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
Zuliani G; Donnorso MP; Bosi C; Passaro A; Dalla Nora E; Zurlo A; Bonetti F; Mozzi AF; Cortese C
BMC Neurol; 2011 Oct; 11():121. PubMed ID: 21970714
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity.
Zarrouk A; Hammami M; Moreau T; Lizard G
Rev Neurol (Paris); 2015 Feb; 171(2):125-9. PubMed ID: 25577946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
